1993•PubMedRequires access
The False Claims Act and clinical laboratories.
Vogel Rl
Open publisher page 0 citations
Abstract
In its efforts to fight fraud, the government has turned increasingly to the civil False Claims Act. The Act imposes triple damages plus monetary penalties against those who defraud the federal government. The Act also encourages whistleblowers to report fraud by offering the prospect of large bounties. This article describes the False Claims Act, its qui tam provision dealing with whistleblowers, and the application of the Act to clinical laboratories.